CancerNetwork Members: Login | Register
CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » EHR

 

Qualitative Evaluation Can Help Keep Your Eye on the EHR Ball

By Daniel Essin, MA, MD | October 8, 2012

EHR implies different things to different people. Many think about and define EHR in terms of a particular system with which they have experience. Others think about EHR in the abstract, questioning what an EHR should do. Many definitions are based on long lists of “requirements” rather than on descriptions of goals and objectives. The number of definitions probably exceeds the number of people who have given it any thought and there is no consensus about the details. There should be little to quibble about with the following common-sense, high-level definition of EHR:

An EHR is a computer system that combines a lifetime medical record with functions that improve the efficiency and effectiveness of the patient care process, the goal of which are to reduce risk to patients and improve outcome. The extent to which a computer system helps a practice achieve these goals can be evaluated either qualitatively or quantitatively. A qualitative approach avoids the ever-present urge that many have to nit-pick about the details while missing the big picture.

(MORE: With EHR Use, Computer Literacy Misses the Point)

As an example, the following is an extensive quote from the latest drug bulletin published by our hospital pharmacy:

High Risk Medication Administration Shortcuts

When medication administration policies and procedures are circumvented to save time medication errors occur. Please avoid the following high risk behavior (shortcuts) regardless of how much time it may save.

• Administering medications before verifying that it is the right patient and right drug.
• Skipping important double-checks due to time constraints.
• Preparing IV solutions on the unit, thus bypassing pharmacy verification and specialized aseptic techniques
• Administering medications before conducting a physical assessment of the patient and/or checking vital signs, lab values, weight, and allergy status
• Removing medications from automated dispensing cabinets (PIXIS) via override without a pharmacist’s review
• Borrowing medications from one patient to administer to another patient
• Not thinking critically about drug administration while rushing through verification of new orders and actual drug administration
• Documenting administration at the scheduled time, but actually giving the drug early or late
• Altering drug administration schedules to avoid documenting late administration
• “Pre-pouring” medications ahead of time for one or more patients to accelerate the drug administration process
• Leaving medications in the room for the patient to take at the right time.

These are all worthy objectives and achieving them would be much more meaningful, in terms of patient safety and outcome, than any of the “meaningful use” criteria established by the government.

There is a simple way to decide whether an EHR can be of value here. Perform a qualitative assessment of how well an EHR meets the definition presented above. To do this, simply go though the list of goals and objectives, such as the ones in the drug bulletin, and ask: Does the EHR help, interfere with, or have no impact on achieving each goal. For those with a statistical inclination, the Sign Test (a non-parametric statistic) can be used to determine whether there are enough positive answers, relative to the negatives, to conclude that the EHR is demonstrably beneficial.

Consider two of the largest-selling EHRs, Epic and Cerner. Based on anecdotal evidence from users and the notorious YouTube video of Epic, it would be of little help in achieving any of these pharmacy-related objectives. A published report [Yong Y. Han, Joseph A. Carcillo, Shekhar T. Venkataraman, Robert S.B. Clark, R.; "Unexpected Increased Mortality After Implementation of a Commercially Sold Computerized Physician Order Entry System"] suggests that the Cerner system is difficult or impossible to configure in a way that it would be beneficial with respect to these pharmacy objectives.

The goals and objectives of a practice are not limited to pharmacy issues. Similar lists can be compiled that address preventive measures, work flow issues, disease-state management, care coordination, etc. One might go so far as to say that if a practice has not developed those lists before embarking on an EHR acquisition then there will be no objective criteria on which to base any decision; no way to assess whether a particular EHR could be of benefit prior to adoption; and no way to tell whether the benefit was obtained after implementation. If the EHR cannot be expected to provide benefit, why spend billions on it? If does not provide benefit once it is in use, why continue to sink money into it? If the product does not conform to the definition presented above, is it an EHR at all, or merely a business-oriented system dressed in clinical clothing?

 

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.

More from Daniel Essin

Qualitative Evaluation Can Help Keep Your Eye on the EHR Ball

EHRs in the Cloud: Hiding Flaws Don't Make Them Disappear

ONCHIT Direct Project a Win for Health IT

The Yin and Yang of Data and the Impact on EHRs

EHRs and Interoperability: Back to the Drawing Board

EHR Construction Doesn't Always Include the Right Tools

The Medical-Industrial Complex

Can Physicians Apply Preventive Medicine Knowledge to EHR?

EHRs: Weighing Form vs. Function

The Ethical Dilemma Created by EHRs

Waste Avoidance: The New Mantra in Healthcare Spending

Reimagining Personal Health Devices

EHR-stored Health Data: Access Issues Confront Cloud Innovation

EHRs a Prime Example of Medicine's 'Software Crisis'

Meaningful Statistics — Can Your EHR Produce Them?

Imagining a Day in Medical Practice with a Possible Future of EHR

EHR Interoperability: I'll Know It When I See It

'Content Neutrality' and Why It Is Important for EHR

The Perils of Over Specification and Underspecification in EHR Systems

IBM's Watson: Has the Time Come for Expert Systems in Medicine?

With Any EHR, Theory is Important but So is Practicality

Doctors Need More Control over the Care Process and EHR is Little Help

With EHRs, Less Patient Data May Be More — Up to a Point

Improve EHR Systems by Rethinking Medical Billing

With EHRs, When Seeking Clarity, Begin at the Beginning

Pondering the Justification for the Federal HIT Push of EHRs

Words Can Be a Window into Fuzzy Thinking about EHRs

One Physician’s New Year's Resolutions

EHRs Only One Victim of Reaction vs. Reason in Healthcare

ICD-10 Shouldn’t Dictate Patient Care or EHR Design

Who Really Benefits from the ICD-10 Transition?

Medical Coding’s Intent is Sometimes Lost in Translation

Medical Informatics — The Debate of Art vs. Science Is Over

Is the EHR Glass Half-Full or Half-Empty?

EHRs and Cars: Don’t Let Perception Cloud Purpose

The Probable Consequences of EHR Certification are Scary

Will an EHR Ever Last as Long as a Patient?

Clinical Quality Measures: Meaningless in Measuring Quality

Interoperability in Healthcare – Easy to Say, Hard to Do

EHRs: Weighing Incentives and What's Best for Patients

With EHRs, Sometimes Less is More

EHR Systems Should Be Taking Larger Strides, But Aren't

Meaningful Use Marches On

To Be or Not To Be an EHR in the Cloud

EHR Cloud Computing Meets Moore's Law

With EHR Use, Computer Literacy Misses the Point





CancerNetwork on Facebook


 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
   SEARCH MEDICA RX
   Browse drugs by name:
A B C D E F G H I J
K L M N O P Q R S T
U V W X Y Z All      
   Search for drugs:
Search

 

 
FROM PHYSICIANS PRACTICE
Primary Care Can't Thrive Without Nurse Practitioners
Courtney H. Lyder, ND,  May 17, 2013
With a projected shortfall of primary-care physicians, it's time for alternate solutions to patient care. Nurse practitioners are one logical remedy.
VWhat Physicians Can Learn from the Allscripts EHR Lawsuit
Marisa Torrieri,  May 16, 2013
Lawsuit prompts question: What should physicians do to ensure they end up with a great EHR instead of buyer’s remorse?
Eight Ways ICD-9 Will Still Matter to Medical Practices
Brenda Edwards, CPC,  May 15, 2013
What should your medical practice do with your ICD-9-CM book after October 1, 2014? Keep it.
Seven Ways Technology Can Speed Up Patient Collections
Cheyenne Brinson,  May 15, 2013
Failing to adopt widely available billing and collections technology can cost medical practices big. Here's how to do it right.
Four Reasons Private Medical Practice is Becoming Extinct
Carol Stryker,  May 15, 2013
It’s becoming increasingly difficult for private medical practices to thrive. Here’s what’s driving the trend toward consolidation.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Skin Lesions
  • Colorectal Lesions
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • ONS: Understanding Spirituality and How It Can Be Used to Help Patients
  • Colorectal Lesions
  • New AUA Guidelines for Prostate Cancer Screening
  • 50 Shades of Pink—And Why It Helps to Know the Difference
  • Genomics Studies Identify Testicular Cancer Risk Variants
  • Lower Back Pain in an Elderly Man With a History of Localized Prostate Cancer
  • FDA Approves Erlotinib (Tarceva) as First-Line Lung Cancer Therapy for Certain Patients
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • “This Is My Last Day on Earth”
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Patient Quality of Life Endpoints in Oncology Trials, Part II
  • Who's Coding Whom?
  • “How Do I Say This Nicely? Your Oncologist Wasn't Following Guidelines”
  • Study: Cholesterol Drugs Reduced Risk of Prostate Cancer Death
  • “This Is My Last Day on Earth”
  • ONS: Safe Handling of Chemotherapy
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Conflicts of Interest in Medicine: What About Ties to Payers?
Click here to subscribe to our newsletter


 
SearchMedica Search Result

Find peer-reviewed literature and websites for practicing medical professionals

CME on EHR
Evidence on EHR
Guidelines on EHR
Patient Education on EHR
Clinical Trials on EHR
Practical Articles on EHR
Research and Reviews on EHR
All "EHR" results


CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy